Eggehard Holler Selected Research

Triple Negative Breast Neoplasms

12/2013	Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
1/2012	Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eggehard Holler Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 01/2006
12	Glioma (Gliomas) 11/2020 - 01/2006
10	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2005
8	Brain Neoplasms (Brain Tumor) 10/2021 - 01/2006
5	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 09/2015
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2006
2	Triple Negative Breast Neoplasms 12/2013 - 01/2012
1	Inflammation (Inflammations) 01/2018
1	Amyloid Plaque 09/2015
1	Lung Neoplasms (Lung Cancer) 05/2015
1	Infections 03/2015
1	Hemorrhage 03/2015
1	Carcinoma (Carcinomatosis) 01/2005

Drug/Important Bio-Agent (IBA)

13	poly(malic acid)IBA 01/2019 - 01/2006
11	Antisense OligonucleotidesIBA 01/2017 - 01/2006
9	malic acid (malate)IBA 01/2023 - 03/2006
9	NanoconjugatesIBA 01/2022 - 03/2006
6	PolymersIBA 10/2021 - 01/2008
6	polycefinIBA 11/2013 - 01/2006
5	Transferrin Receptors (Transferrin Receptor)IBA 03/2012 - 01/2006
5	MorpholinosIBA 01/2012 - 01/2006
4	Peptides (Polypeptides)IBA 01/2022 - 03/2012
4	AntibodiesIBA 01/2019 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 10/2007
4	Monoclonal AntibodiesIBA 01/2012 - 03/2006
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	Contrast MediaIBA 01/2020 - 05/2015
3	Biopolymers (Biopolymer)IBA 01/2019 - 03/2006
3	laminin 8IBA 10/2007 - 01/2006
2	Particulate MatterIBA 10/2023 - 01/2018
2	leucyl-leucyl-leucineIBA 01/2023 - 10/2010
2	DisulfidesIBA 01/2023 - 03/2006
2	epidermal growth factor receptor VIIIIBA 10/2021 - 12/2016
2	GadoliniumIBA 01/2020 - 09/2015
2	ErbB Receptors (EGF Receptor)IBA 12/2016 - 12/2013
2	CurcuminIBA 09/2015 - 09/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2012 - 01/2012
2	Fluorescent Dyes (Fluorescent Probes)IBA 02/2012 - 03/2006
2	Nucleosomes (Nucleosome)IBA 01/2012 - 10/2007
2	EstersIBA 10/2010 - 01/2010
2	Laminin (Merosin)IBA 03/2006 - 01/2005
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Antisense RNA (Anti-Sense RNA)IBA 01/2023
1	ferric oxide (iron oxide)IBA 10/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	NestinIBA 01/2019
1	CTLA-4 AntigenIBA 01/2019
1	ChlorotoxinIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Nanoparticle Drug Delivery SystemIBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016
1	Glatiramer Acetate (Copaxone)FDA Link 09/2015
1	Retinaldehyde (Retinal)IBA 09/2015
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 05/2015
1	Interleukin-2 (IL2)IBA 11/2013
1	Oncogene Proteins (Oncogene Protein)IBA 11/2013
1	Immunoglobulin G (IgG)IBA 11/2013
1	CytokinesIBA 11/2013
1	Dendrimers (Dendrons)IBA 11/2013
1	Liposomes (Liposome)IBA 11/2013
1	MicellesIBA 11/2013
1	CarbonIBA 11/2013
1	Biotin (Vitamin H)FDA Link 02/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 02/2012
1	poly(benzyl malate)IBA 02/2012
1	LigandsIBA 02/2012
1	HydrazonesIBA 01/2012
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2012
1	Trastuzumab (Herceptin)FDA Link 02/2011
1	ErbB-2 ReceptorIBA 02/2011
1	Messenger RNA (mRNA)IBA 02/2011
1	Alkylating AgentsIBA 11/2010
1	ProdrugsIBA 11/2010
1	Temozolomide (Temodar)FDA LinkGeneric 11/2010
1	A-Form DNA (A-DNA)IBA 11/2010
1	Leucine (L-Leucine)FDA Link 10/2010
1	OligonucleotidesIBA 03/2006
1	Ethylene Glycol (Monoethylene Glycol)IBA 03/2006
1	S 6 (S-6)IBA 03/2006
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	Valine (L-Valine)FDA Link 03/2006
1	Protein Isoforms (Isoforms)IBA 01/2005

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2005
2	Intravenous Injections 01/2020 - 10/2007
2	Drug Therapy (Chemotherapy) 01/2012 - 01/2012
1	Immunotherapy 09/2015
1	Bandages (Bandage) 03/2015
1	Precision Medicine 06/2014
1	Ligation 06/2014
1	Injections 01/2008
1	Subcutaneous Injections 01/2008